Statins and survival in a cohort of veterans with chronic lymphocytic leukemia (CLL). This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text ...
The model suggests that negative KRAS findings are believable when the maximum of APC and TP53 frequencies is at least 8% (corresponding posterior probability of false negative <5%). Validation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback